The Company is a Korea-based company mainly engaged in the development and manufacture of cell culture medium. The Company mainly conducts research, development and production of cell culture media, a material for biopharmaceuticals. The Company was established on September 14, 2015. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 15, 2024.
Headquarters
333, Yeongdongdae-Ro, Gangnam-Gu
Seoul; Seoul;
Contact Details: Purchase the Xcell Therapeutics Inc. report to view the information.
Website: http://www.xcell.media
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service